Seed Biotech's management team is composed of highly skilled and experienced individuals dedicated to the vision of never-ending improvement of manufactured products for better patient outcomes as well as generating growth and profitability.
Ryanne is the brains behind our operation, she believed that the tissue banking world could be dramatically improved and set about to improve both the quality and efficiency of current tissue processing methods. She is experienced in the discovery, development and strategic commercialization of innovative technologies in the fields of Orthopedic, Neurosurgical, Dental, and Surgical Specialties Medical Devices. Ryanne has worked with numerous companies in the industry, including RTI Surgical, Mimedx, MTF and Axogen. After acting solely as Quality Assurance Director, Ryanne then became Chief Scientific Officer and is currently the Chief Executive Officer. Ryanne sits on the Birth Tissue Group for the American Association of Tissue Banks and holds a Bachelor of Science in Engineering from the University of Florida and a Master's in Biomedical Engineering from Cal Poly State University.
Christian founded Seed Biotech to help make a difference and change patient outcomes. He has a long history in finance, real estate and law with a focus on affordable multifamily housing. Christian teamed up with his wife Ryanne to bring Seed Biotech from a vision to a reality, with the goal of creating better products at price points that would be available to a larger patient population. After being Seed Biotech's CEO he is currently the President and CFO. He holds a Bachelor of Business Administration from Emory University, a Master's in Real Estate from the University of Florida and a Doctor of Jurisprudence from The University of Houston Law Center. Christian is a member of the State Bar of Texas.
Holly ensures the continuous improvement of quality, business and staff development at Seed Biotech. She has 25 years of experience in the healthcare and biotechnology industries with a focus on new product commercialization, business development and international market penetration. Holly has worked with numerous companies in the industry, including Tissue Tech Inc., Osiris Therapeutics Inc and AxoGen. Holly is a member of the American and European Associations of Tissue Banks and holds a Bachelor of Science in Biology from the University of South Carolina and a Masters of Business Administration in International Business from Kaplan University.
Kirk joined Seed Biotech's executive team in 2017 as the head of marketing and sales to help the company grow its portfolio of clients and allow our products' potential to reach more needing patients. Kirk has an overall experience of 20 years in sales in various industries. Kirk holds a Bachelor of Business Administration in Marketing with a specialization in Professional Selling from Baylor University, Texas.
Adeana joined Seed Biotech in 2014 and oversees critical functions relating to quality assurance including quality reviews and inspections performed by staff to ensure compliance is maintained. In addition to acting as management representative at Seed Biotech, Inc., Adeana is responsible for conducting internal audits of the Quality Program. Adeana graduated from the University of Florida with a Bachelor of Science in Psychology. Additionally, she is CTBS certified and is a member of the American Association of Tissue Banks.
Rachel Jewell - Inventory and Processing Control Manager
Rachel joined Seed Biotech as a quality and technical asset from the beginning of Seed’s operations. In 2014, Rachel became our Quality Assurance Supervisor, assisting through an FDA audit and was a crucial resource in acquiring our AATB Accreditation. Rachel has always felt a calling to the Tissue Banking world and has been since become our Inventory and Processing Control Manager.